Although an additional frameshift deletion in TSC2 was identified in smooth-muscle differentiation AML in ∼28% (11.39) of reads, it is unlikely to act as the second hit because of the apparent absence in the epithelioid differentiated AML sample. The gene discussed is TSC2; the disease is acute myeloid leukemia.